🔬 Silence APOC3, Slash Triglycerides, A New Era in Triglyceride Control
Dr RR Baliga's "Got Knowledge Doc" Podkast
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
🚨 New NEJM Study on Olezarsen 🚨
In patients with moderate hypertriglyceridemia and elevated cardiovascular risk, monthly subcutaneous olezarsen reduced triglycerides by over 60% at 6 months! 📉💥
✅ Significant drops in APOC3, VLDL, remnant & non-HDL cholesterol
✅ No rise in LDL-C
✅ Well-tolerated with mild injection-site reactions
🔬 APOC3 inhibition emerges as a game-changer in lipidology.
📖 ESSENCE–TIMI 73b Trial | Funded by Ionis Pharmaceuticals
#Cardiology #LipidLowering #PrecisionMedicine #NEJM #Olezarsen #TGlowering #CVRisk #TIMI #Atherosclerosis #GenomicTherapy 🧬💊🫀